当前位置: 首页 > 期刊 > 《中国保健营养.中旬刊》 > 20137
编号:13724403
根除幽门螺杆菌治疗中血清胃蛋白酶原变化的临床观察(2)
http://www.100md.com 2013年7月1日 《中国保健营养·中旬刊》 20137
     参考文献:

    [1] 姜海行,李君武,施焕中.幽门螺杆菌诱导大鼠胃黏膜分泌胃蛋白酶原[J].中华微生物学和免疫学杂志,2000,21(7):381.

    [2] 张钰,朱振龙,霍晓辉,等.与幽门螺杆菌相关的胃外疾病[J].临床荟萃,2006,21(19):1437-1438.

    [3] 胡伏莲,周殿元.幽门螺杆菌感染的基础与临床[M]. 修订版,北京:中国科学技术出版社,2002:329-375,309-310.

    [4] Samlott I M.Liebman W M.Cellular locatization of the groupⅡpepsinogens in human stomach and duodenum by immunoaores cence[J].Gastroententerology,1973(65):35—42.

    [5] Lorente S,Doiz o,serrano MT,Castillo I,Lanas A.Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells.Gut 2002;50:13一18.

    [6] 黄象谦.幽门螺杆菌感染与胃肠激素的联系.世界华人消化杂志 2000:8:1079-1083.

    [7] Merta HR Peterson WL,Walsh JH.Farmillial Hyperpepsinogenemia and Helicobacter pylori infection.Am J Gastroenterol 2000;95:943-946

    [8] Kikuchi S,Kurosawa M,Sakiyama T,Castillo T,Lanas A.Long-term effect of Helicobacter pylori infection on serum Pepsinogen.Jpn,J Cancer, Res 2000;9:471-476.

    [9] Karita M,Noriyasu A,Kosako E.Relationship between pepsinogen I&Ⅱand H pylori infection considered with grade of atrophy and gastroduodenal.Dig Dis Sci 2003:48:1839-1845.

    [10] Ito M,Harama K,Kamada T.Helicobacter pylori eradication therapy improved atrophic gastritis and intestinal metaplasia:a 5-year prospective study of patients with atrophic gastritis.Aliment Pharmacol Ther 2002;16:1449-1456., http://www.100md.com(刘琪)
上一页1 2